Home > Client Services > Client List > Bristol-Myers Squibb
 

Bristol-Myers Squibb Jobs Profile



This profile is a brief introduction for people seeking employment in pharmaceutical graduate jobs, pharmaceutical nurse advisors, pharmaceutical sales jobs, pharmaceutical training jobs, pharmaceutical sales management jobs, pharmaceutical marketing jobs, pharmaceutical executive jobs, or pharmaceutical clinical research associates who may be considering working for Bristol-Myers Squibb.  

 Best Companies        

Company Overview

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

Our medicines are making a difference in the lives of millions of customers across the globe. And by living our mission and growing our company for well over a century, we are making a difference in the lives of our shareholders, employees and neighbours as well.

Bristol-Myers Squibb is one of the leading pharmaceutical companies in the world. For over half a century, we have been pioneers in the research and development of important medicines. Bristol-Myers Squibb is the number one provider worldwide of anti-cancer therapies, as well as a leader in the discovery and development of innovative treatments to fight heart disease, high blood pressure, stroke, type 2 diabetes, HIV/AIDS and other infectious diseases, depression, anxiety and pain.


Product Overview

Abilify (aripiprazole)
Avapro (irbesartan)
Baraclude (entecavir)
Cardiolite (Kit for the preparation of Technetium Tc99m Sestamibi for Injection)
ConvaTec Ostomy Care
ConvaTec Wound Therapeutics
Enfamil (Infant Formula)
Erbitux (Cetuximab)
Orencia (abatacept)
Plavix (clopidogrel bisulfate)
Pravachol (pravastatin sodium) Tablets

 Reyataz (atazanavir sulfate)
Sustiva (efavirenz)TAXOL (paclitaxel) Injection
Videx EC (didanosine, delayed-release capsules)
Zerit (stavudine)

 

 

 

 

 

 

 

 

 

 



Dean
Bristol-Myers Squibb Account Manager
01494 818 019
(Mon to Fri 0830 to 1800 hours)
dean@zenopa.com

Please contact the Account Manager for opportunities with this organisation

News

Bristol-Myers Squibb announces ConvaTec deal complete
Bristol-Myers Squibb has revealed Nordic Capital Fund VII and Avista Capital Partners have bought ConvaTec, one of their business units.

Bristol-Myers Squibb, Otsuka Pharmaceutical receive expanded drug indications
Bristol-Myers Squibb and Otsuka Pharmaceutical have been granted expanded indications for the application of Abilify as a treatment for Bipolar I Disorder and Schizophrenia among paediatric patients.

Bristol-Myers Squibb to sell ConvaTec
Bristol-Myers Squibb has announced that it has signed a definitive agreement to sell its ConvaTec unit to Nordic Capital Fund VII and Avista Capital Parners.

Bristol-Myers Squibb reports double-digit net sales growth
Bristol-Myers Squibb has announced its financial results for the first quarter of the 2008 fiscal year.

Bristol-Myers Squibb and Shire name results dates
Pharmaceutical companies Bristol-Myers Squibb and Shire have announced the release of their first quarter results.


home | our clients | browse news | browse jobs | links | hotel directory | copyright © 2008 Zenopa Ltd | terms & conditions of use